| ¿µ¹® | central nervous system(CNS) | ÇÑ±Û | ÁßÃ߽Űæ°è |
|---|---|---|---|
| ¼³¸í | ½Å°æ°è´Â ÁßÃ߽Űæ°è¿Í ¸»ÃʽŰæ°è·Î ºÐ·ùÇÒ ¼ö°¡ ÀÖ´Ù. ÁßÃ߽Űæ°è¶õ ³ú¿Í ô¼ö·Î ±¸¼ºµÇ¾î ÀÖ´Â ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. ¸»ÃʽŰæ°è¶õ ÀÌ ÀÌ¿ÜÀÇ ¸ðµç ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | vegetative state | ÇÑ±Û | ½Ä¹°»óÅ |
|---|---|---|---|
| ¼³¸í | ÀÚÀ²½Å°æ°è´Â Ȱµ¿Çϰí ÀÖÀ¸³ª ¼öÀǿÀÌ ÀüÇô ºÒ´ÉÇÑ »óŸ¦ ¸»ÇÑ´Ù. µû¶ó¼ È£Èí, ½É¹ÚÀº Áö¼ÓÇϰí ÀÖÀ¸³ª ÀǽÄÀûÀΠȰµ¿À» ÀÏÀ¸Å°´Â ÀÏÀº ÇÒ ¼ö ¾ø´Ù. ¿øÀÎÀº µÎºÎ¿Ü»ó-ôÃß¼Õ»ó-³úÇ÷°ü¼Õ»ó-³úô¼öÁ¾¾ç-Áßµ¶ µî ¿©·¯ °¡Áö°¡ ÀÖÁö¸¸, °¡Àå ¸¹Àº °ÍÀº ±³Åë»ç°í µî¿¡ ÀÇÇÑ ¸Ó¸®¿Ü»óÀÌ´Ù. ´ë³úÀÇ Ç¥ÃþºÎ´Â ´ë³ú°ÑÁúÀ̶ó Çϴµ¥, ÀÌ °÷¿¡´Â ¹é ¼ö ½Ê¾ïÀÇ ½Å°æ¼¼Æ÷°¡ ¸ð¿© ÀÖ¾î¼ ¿îµ¿-°¨°¢-ÀÇ½Ä µîÀÇ ÀÛ¿ëÀ» ´ã´çÇϰí ÀÖ´Ù. ÀÌ ´ë³ú°ÑÁúÀÇ ¼Õ»óÀ» ÀÔÀ¸¸é ¿îµ¿±â´ÉÀ̳ª ÀǽÄÀÌ Á¤ÁöµÇ°í, ³úÁٱⰡ ´ã´çÇϴ ȣÈí±â´É-¼Òȱâ´É-½ÉÀå¹Úµ¿±â´É ¹Û¿¡ ÇÏÁö ¸øÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | persistent vegetative state | ÇÑ±Û | Áö¼Ó½Ä¹°»óÅ |
|---|---|---|---|
| ¼³¸í | ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼ ÀϾ´Â °¢¼º»óÅ¿¡ ÀÖ¾î¼ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Ư¡À¸·Î Çϸç, ³úÆÄ´Â ÆòÅºÈ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù. |
||
| LES | Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru... |
|---|---|
| CES | carboxylesterase; cauda equina syndrome; cat's eye syndrome; central excitatory state; chronic elect... |
| CIS | carcinoma in situ; catheter-induced spasm; central inhibitory state; Chemical Information Service; c... |
| EPSP | Excitatory Post-Synaptic Potential; ÈïºÐ¼º ½Ã³À½ºÈÄ ÀüÀ§ |
| EAA | electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin... |
| EAA | Excitatory Amino acid |
|---|---|
| EAAR | Excitatory amino acid receptor |
| EAAT | excitatory amino acid transporter |
| EAAC1 | Excitatory amino-acid carrier 1 |
| EJC | excitatory junction current |
| central excitatory state | The building up of excitatory influences produced by individual impulses finally causes firing of the next neuron. (05 Mar 2000) |
|---|
| local excitatory state | Increased irritability of a nerve fibre or muscle fibre which is produced by an ineffective electrical stimulus; summation of the stimuli may occur, resulting in a propagated impulse if two or more subliminal stimuli are applied in rapid succession. (05 Mar 2000) |
|---|---|
| excitatory | Tending to produce excitation. (05 Mar 2000) |
| excitatory amino acid | <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins. at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation. Invertebrate glutamate receptors may not have the same properties as those described above. (18 Nov 1997) |
| excitatory amino acid agents | Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids. (12 Dec 1998) |
| excitatory amino acid agonists | Drugs that bind to and activate excitatory amino acid receptors. (12 Dec 1998) |
| excitatory amino acid antagonists | Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (12 Dec 1998) |
| excitatory amino acids | Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear. (12 Dec 1998) |
| excitatory junction potential | Discrete partial depolarisation of smooth muscle produced by stimulation of excitatory nerves; similar to small end-plate potentials. They summate with repeated stimuli. (05 Mar 2000) |
| excitatory postsynaptic potential | The change in potential which is produced in the membrane of the next neuron when an impulse which has an excitatory influence arrives at the synapse; it is a local change in the direction of depolarisation; summation of these potential's can lead to discharge of an impulse by the neuron. (05 Mar 2000) |
| excitatory postsynaptic potentials | The change in potential produced in the membrane of the next neuron when an impulse which has an excitatory influence arrives at the synapse; it is a local change in the direction of depolarisation; summation of these potentials can lead to discharge of an impulse by the neuron. (12 Dec 1998) |
| excitatory synapse | <physiology> A synapse (either chemical or electrical) in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. See: inhibitory synapse. (18 Nov 1997) |
| absent state | The saemiconscious state associated with an epileptic attack. Synonym: absent state. (05 Mar 2000) |
| activated state | <chemistry, radiobiology> An atom or nucleus which possesses more energy than its ground state energy. (16 Dec 1997) |
| acute confusional state | <psychiatry> A condition of severe confusion or rapid change in brain function. This often occurs as the result of a mental illness or physical illness. Symptoms include lethargy, agitation, confusion, disorientation and delirium. (27 Sep 1997) |
| anxiety tension state | A milder form of an anxiety disorder. See: anxiety disorders. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|